← Back to Search

Radiation Therapy

stereotactic radiotherapy for Prostate Cancer (CROP Trial)

Phase 1 & 2
Waitlist Available
Led By Patrick Cheung, M.D.
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 4 years
Awards & highlights

CROP Trial Summary

This trial looks at whether using two cancer treatments together is safe and better than using just one of them for patients with a limited number of metastatic tumours.

CROP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of late radiotherapy toxicities after stereotactic radiotherapy to all sites of disease
Secondary outcome measures
Overall survival
Quality of Life (EORTC QLQ-C30)
Radiographic "distant" control rate
+2 more

CROP Trial Design

1Treatment groups
Experimental Treatment
Group I: Stereotactic radiotherapyExperimental Treatment1 Intervention
Stereotactic radiotherapy will be delivered to the prostate (if not previously treated) and to all metastatic tumours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
stereotactic radiotherapy
2014
N/A
~60

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,347 Total Patients Enrolled
35 Trials studying Prostate Cancer
12,638 Patients Enrolled for Prostate Cancer
Patrick Cheung, M.D.Principal InvestigatorToronto Sunnybrook Regional Cancer Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical trial for new volunteers?

"Unfortunately, this study is no longer recruiting patients according to the clinicaltrials.gov listing. Although the trial originally began on November 1st, 2014, it was ended on March 6th, 2022. There are however 1291 other trials which are still running and actively seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Stereotactic Radiotherapy for Oligometastatic Prostate Cancer
Dr. Patrick Cheung 2014. "Stereotactic Radiotherapy for Oligometastatic Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02563691.
All > Metastatic Prostate Cancer
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top